Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2010 2
2011 5
2012 1
2013 2
2016 1
2017 3
2018 1
2019 8
2020 1
2021 6
2022 6
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events.
Les I, Martínez M, Pérez-Francisco I, Cabero M, Teijeira L, Arrazubi V, Torrego N, Campillo-Calatayud A, Elejalde I, Kochan G, Escors D. Les I, et al. Among authors: arrazubi v. Cancers (Basel). 2023 Mar 6;15(5):1629. doi: 10.3390/cancers15051629. Cancers (Basel). 2023. PMID: 36900420 Free PMC article. Review.
Omics Approaches in Pancreatic Adenocarcinoma.
González-Borja I, Viúdez A, Goñi S, Santamaria E, Carrasco-García E, Pérez-Sanz J, Hernández-García I, Sala-Elarre P, Arrazubi V, Oyaga-Iriarte E, Zárate R, Arévalo S, Sayar O, Vera R, Fernández-Irigoyen J. González-Borja I, et al. Among authors: arrazubi v. Cancers (Basel). 2019 Jul 25;11(8):1052. doi: 10.3390/cancers11081052. Cancers (Basel). 2019. PMID: 31349663 Free PMC article. Review.
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Guigay J, Aupérin A, Fayette J, Saada-Bouzid E, Lafond C, Taberna M, Geoffrois L, Martin L, Capitain O, Cupissol D, Castanie H, Vansteene D, Schafhausen P, Johnson A, Even C, Sire C, Duplomb S, Evrard C, Delord JP, Laguerre B, Zanetta S, Chevassus-Clément C, Fraslin A, Louat F, Sinigaglia L, Keilholz U, Bourhis J, Mesia R; GORTEC; AIO; TTCC, and UniCancer Head and Neck groups. Guigay J, et al. Lancet Oncol. 2021 Apr;22(4):463-475. doi: 10.1016/S1470-2045(20)30755-5. Epub 2021 Mar 5. Lancet Oncol. 2021. PMID: 33684370 Clinical Trial.
Treatment in esophagogastric junction cancer: Past, present and future.
Pericay C, Macías-Declara I, Arrazubi V, Vilà L, Marín M. Pericay C, et al. Among authors: arrazubi v. Cir Esp (Engl Ed). 2019 Oct;97(8):459-464. doi: 10.1016/j.ciresp.2019.03.016. Epub 2019 May 31. Cir Esp (Engl Ed). 2019. PMID: 31155142 Review. English, Spanish.
SEOM-TTCC clinical guideline in nasopharynx cancer (2021).
Rueda Domínguez A, Cirauqui B, García Castaño A, Alvarez Cabellos R, Carral Maseda A, Castelo Fernández B, Iglesias Rey L, Rubió-Casadevall J, Arrazubi V, Mesía R. Rueda Domínguez A, et al. Among authors: arrazubi v. Clin Transl Oncol. 2022 Apr;24(4):670-680. doi: 10.1007/s12094-022-02814-x. Epub 2022 Mar 18. Clin Transl Oncol. 2022. PMID: 35303267 Free PMC article.
State of the Art: ctDNA in Upper Gastrointestinal Malignancies.
Labiano I, Huerta AE, Arrazubi V, Hernandez-Garcia I, Mata E, Gomez D, Arasanz H, Vera R, Alsina M. Labiano I, et al. Among authors: arrazubi v. Cancers (Basel). 2023 Feb 21;15(5):1379. doi: 10.3390/cancers15051379. Cancers (Basel). 2023. PMID: 36900172 Free PMC article. Review.
Chemoradiation of rectal cancer.
Arrazubi V, Suárez J, Novas P, Pérez-Hoyos MT, Vera R, Martínez Del Prado P. Arrazubi V, et al. Minerva Chir. 2013 Feb;68(1):11-26. Minerva Chir. 2013. PMID: 23584263 Review.
[Orbital metastases of breast cancer].
Illarramendi Mañas JJ, Salgado E, Lainez N, Arrazubi V, Teijeira L, Vera R. Illarramendi Mañas JJ, et al. Among authors: arrazubi v. An Sist Sanit Navar. 2008;31 Suppl 3:135-45. An Sist Sanit Navar. 2008. PMID: 19169301 Free article. Review. Spanish.
New drug development in digestive neuroendocrine tumors.
Durán I, Salazar R, Casanovas O, Arrazubi V, Vilar E, Siu LL, Yao J, Tabernero J. Durán I, et al. Among authors: arrazubi v. Ann Oncol. 2007 Aug;18(8):1307-13. doi: 10.1093/annonc/mdm009. Epub 2007 Feb 13. Ann Oncol. 2007. PMID: 17301070 Free article. Review.
45 results